Institute for Bioscience and Biotechnology Research (IBBR)

To join researchers in academia with corporate and government partners to develop solutions that address major health and scientific challenges, benefit patients, and create economic development in the state.

 A partnership of UMB, UMCP, and the National Institute of Standards and Technology, IBBR forms key alliances with biopharmaceutical companies and federal agencies. IBBR provides national infrastructure support to the biopharmaceutical industry through a nationwide public-private partnership.

Researchers are developing a vaccine for hepatitis C and for HPV (a common cause of cervical cancer) in conjunction with Leidos Biomedical Research, Inc., and the Frederick National Laboratory for Cancer Research.

Through MPower, IBBR supports teams of researchers in gathering information necessary to take basic research discoveries and advance them to commercial and medical applications.


Institute for Bioscience and Biotechnology Research


  • Categories: Research